Line A. Ryberg
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Computational Drug Discovery Methods
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 4
- Viral gastroenteritis research and epidemiology 2
- COVID-19 Clinical Research Studies 2
-
- Protein Structure and Dynamics 3
- Protein Interaction Studies and Fluorescence Analysis 2
- Protein purification and stability 1
- Co-authors
- Günther H. Peters (7 shared papers)Ulrik Fahnøe (7 shared papers)Jens Bukh (7 shared papers)Long V. Pham (6 shared papers)Judith M. Gottwein (4 shared papers)Santseharay Ramírez (7 shared papers)Carlota Fernandez-Antunez (4 shared papers)Anna Offersgaard (3 shared papers)
- Journals
- Emerging Microbes & Infections (2 papers)Viruses (2 papers)Molecular Pharmaceutics (1 paper)Acta Crystallographica Section D Structural Biology (1 paper)Antiviral Research (1 paper)
- Partner nations
- DenmarkSwitzerlandBelgium
In The Last Decade
Line A. Ryberg
10 papers receiving 300 citations
Line A. Ryberg's Hit Papers
Peers
Comparison fields: 5 of 58
- Infectious Diseases 169
- Computational Theory and Mathematics 65
- Geriatrics and Gerontology 6
- Molecular Biology 103
- Pharmaceutical Science 9
Countries citing papers authored by Line A. Ryberg
This map shows the geographic impact of Line A. Ryberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line A. Ryberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line A. Ryberg more than expected).
Fields of papers citing papers by Line A. Ryberg
This network shows the impact of papers produced by Line A. Ryberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line A. Ryberg. The network helps show where Line A. Ryberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Line A. Ryberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Hit paper breakdown → | 2022 | 138 |
| 2 | 2021 | 66 | |
| 3 | 2015 | 46 | |
| 4 | 2019 | 14 | |
| 5 | 2023 | 10 | |
| 6 | 2019 | 10 | |
| 7 | 2023 | 10 | |
| 8 | 2024 | 5 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2026 | 0 |
About Line A. Ryberg
Line A. Ryberg is a scholar working on Infectious Diseases, Molecular Biology, Animal Science and Zoology, Geriatrics and Gerontology and Computational Theory and Mathematics, having authored 11 papers that have together received 301 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (4 papers), Protein Structure and Dynamics (3 papers), Protein Interaction Studies and Fluorescence Analysis (2 papers), Viral gastroenteritis research and epidemiology (2 papers), COVID-19 Clinical Research Studies (2 papers), Animal Virus Infections Studies (2 papers) and Protein purification and stability (1 paper). The work is most often cited by research in Infectious Diseases (169 citations), Computational Theory and Mathematics (65 citations), Geriatrics and Gerontology (6 citations), Molecular Biology (103 citations) and Pharmaceutical Science (9 citations). Line A. Ryberg has collaborated with scholars based in Denmark, Switzerland and Belgium. Frequent co-authors include Günther H. Peters, Ulrik Fahnøe, Jens Bukh, Long V. Pham, Judith M. Gottwein, Santseharay Ramírez, Carlota Fernandez-Antunez, Anna Offersgaard, Alekxander Binderup and Karen Anbro Gammeltoft. Their work appears in journals such as Emerging Microbes & Infections, Viruses, Molecular Pharmaceutics, Acta Crystallographica Section D Structural Biology and Antiviral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.